Faron Pharmaceuticals completes placing of Ordinary Shares on AIM
Clients Faron Pharmaceuticals Oy
Jones Day represented Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company based in Turku, Finland, in connection with the placing of Ordinary Shares on the Alternative Investment Market (AIM). Cairn Financial Advisors acted as nominated advisor. Panmure Gordon acted as joint nominated broker and bookrunner. Whitman Howard acted as joint nominated broker.